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Tablet dosage formA novel simple, direct and selective gas chromatography–mass spectrometry (GC/MS) proce-
dure was developed for the determination of the antihistamine drug dimenhydrinate (DMH)
in presence of six of its related substances and potential impurities, namely, diphenylmethane,
diphenylmethanol, benzophenone, orphenadrine, caffeine and 8-chlorocaffeine. The method
involved resolution of the underivatized compounds using a triﬂuoropropylmethyl polysiloxane
(Rtx-200) capillary column and the mass spectrometric detection was carried out in the electron-
impact (EI) mode. Excellent baseline separation of DMH and the cited related substances was
achieved in less than 15 min. Quantiﬁcation of the parent drug DMH was based on measuring
its peak area. The reliability and analytical performance of the proposed method were validated
with respect to linearity, range, precision, accuracy, speciﬁcity, robustness, detection and quan-
tiﬁcation limits. Calibration curve of DMH was linear over the range 50–500 lg/mL with deter-
mination coefﬁcient (R2) = 0.9982. The proposed method was successfully applied for the assay
of DMH in tablets dosage form with recoveries >96.80%.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Cairo University.Introduction
Dimenhydrinate (DMH) is the diphenhydramine salt of 8-
chlorotheophylline. It is chemically known as a (1:1) com-
pound of 8-chloro-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-
dione with 2-(diphenylmethoxy)-N,N-dimethylethanamine [1].
DMH is an antihistamine with antimuscarinic and signiﬁcant
sedative effects [2]. It is mainly used as an antiemetic in the
prevention and treatment of motion sickness [2]. It is also used
for the symptomatic treatment of nausea and vertigo caused by
54 T.S. Belal et al.Me´nie`re’s disease and other vestibular disturbances [2]. The
quantiﬁcation of DMH in various drug formulations and/or
biological samples was addressed in several reports. Analytical
methodology in these reports involved the use of spectropho-
tometry [3,4], adsorptive stripping voltammetry [5], capillary
electrophoresis [6], liquid chromatography–tandem mass
spectrometry (LC/MS/MS) [7], high performance liquid
chromatography (HPLC) with ﬂuorescence detection [8],
HPLC with UV detection [9] and high performance thin
layer chromatography (HPTLC) [10,11]. Recently, an
electrochemical method based on batch injection analysis with
multiple pulsed amperometric detection was reported for
stoichiometric determination of DMH [12].
Few GC/MS methods could be found in the scientiﬁc lit-
erature for the analysis of DMH merely for toxicological
and forensic purposes [13,14]. Furthermore, few articles
described the application of gas chromatography (GC) in ana-
lysis of diphenhydramine which is one of the two components
of DMH. The simultaneous determination of diphenhy-
dramine and pseudoephedrine in cough syrup was carried
out using GC with ﬂame ionization detector (FID) [15]. On
the other hand, GC coupled with either nitrogen–phosphorus
detection (NPD) or mass selective detection (MSD) was
exploited for the determination of diphenhydramine in several
biological samples [16,17]. Finally, GC/MS was applied for the
identiﬁcation of diphenhydramine and its metabolites along
with other drugs commonly detected in clinical toxicology
laboratories [18].
Although not widely used in pharmaceutical analysis,
GC/MS can be considered one of the powerful techniques
for separation and analysis of complex mixtures. WeO
N
N
N N
H
N
O
O
Cl
Dimenhydrinate
O
N
Orphenadrine
Diphenylmethane
OH
Diphenylmethanol (Benzhydrol)
O
Benzophenone
N
N N
N
O
O
Caffeine
N
N N
N
O
O
Cl
8-Chlorocaffeine
Fig. 1 Structures of the parent compound dimenhydrinate and
the related substances involved in the study.previously published the selective determination of some phar-
maceutical compounds in presence of their related substances
using direct GC/MS methods [19,20]. Reviewing the literature
revealed the use of gradient elution RP-HPLC with UV detec-
tion methods for the separation of DMH together with its
related substances and impurities [21,22]. DMH related sub-
stances which are involved in this study are diphenylmethane,
diphenylmethanol (benzhydrol), benzophenone, orphenadrine,
caffeine and 8-chlorocaffeine [21–23]. Chemical structures of
the parent drug and the related substances are shown in
Fig. 1. To the best of our knowledge, there were no reports
for the application of GC/MS in the analysis of DMH in phar-
maceutical preparations. Additionally, there were no GC
reports for the selective determination of DMH in presence
of its related substances, degradation products or impurities.
This work describes a simple, direct and selective capillary
GC/MS method for the separation of DMH together with
the above-mentioned related substances. The described
method proved to be suitable for the quality assessment of
DMH in its tablets.
Experimental
Materials
Dimenhydrinate, diphenylmethane, diphenylmethanol (ben-
zhydrol), diphenylmethanone (benzophenone), orphenadrine
hydrochloride, caffeine and 8-chlorocaffeine were purchased
from Sigma–Aldrich Co. (St. Louis, MO, USA). HPLC-grade
acetonitrile was purchased from Fisher Scientiﬁc (Fair Lawn,
NJ, USA). Pharmaceutical preparation examined in this study
is Dramamine tablets (Batch No. 133542, Prestige Brands,
Inc., Tarrytown, NY, USA) labeled to contain 50 mg DMH
per tablet.
General procedure and construction of calibration graph
DMH and its related substances are all readily soluble in ace-
tonitrile. DMH (1000 lg/mL) stock solution was prepared in
acetonitrile. DMH working solutions were prepared by dilu-
tion of aliquots of the stock solution with acetonitrile to reach
the concentration range 50–500 lg/mL. The prepared working
solutions were analyzed under the described GC/MS condi-
tions under Instrumentation. The peak areas were plotted
against the corresponding concentrations to construct the
calibration graph.
Stock solutions of the six related substances (1000 lg/mL)
were separately prepared in acetonitrile. Aliquots of these
stock solutions were added to an aliquot of the parent com-
pound stock solution and the mixture was diluted with ace-
tonitrile. This mixture was analyzed under the described GC
conditions.
Assay of tablets dosage form
A total of 10 tablets were weighed and ﬁnely powdered. Ace-
tonitrile (30 mL) was added to an accurately weighed quantity
of the powdered tablets equivalent to 50 mg DMH, stirred for
10 min then ﬁltered into a 50-mL calibrated ﬂask. The residue
was washed with 2 · 5 mL acetonitrile and washings were
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trile. Aliquots of the tablet solution were diluted with acetoni-
trile to obtain ﬁnal concentrations within the range 50–500 lg/
mL DMH and then treated as under general procedure.
Instrumentation
The GC/MS system consisted of an Agilent Technologies
(Santa Clara, CA, USA) 7890A gas chromatograph and an
Agilent 7683B auto injector coupled with a 5975C VL Agilent
mass selective detector. The injection volume was 1 lL. The
mass spectral scan rate was 2.86 scans per second. The GC
was operated in splitless mode with a carrier gas (helium grade
5), ﬂow rate was 0.7 ml/min and a column head pressure of
10 psi. The mass spectrometer was operated on the electron
impact (EI) mode using an ionization voltage of 70 eV and a
source temperature of 230 C. The GC injector was maintained
at 300 C and the transfer line at 275 C. The temperature pro-
gram used consisted of an initial temperature hold at 100 C
for 1 min, ramped up to 180 C at a rate of 25 C/min and
holding the temperature at 180 C for 8 min then the tem-
perature was ramped up to 250 C at a rate of 25 C/min.
The mass spectra were obtained by background subtraction
and are the average of at least ﬁve scans. The chromatographic
separation was carried out on a 30 m · 0.25 mm-i.d. column
coated with 0.25 lm triﬂuoropropylmethyl polysiloxane
(Rtx-200) purchased from Restek Corporation (Bellefonte,
PA, USA). The study was carried in the GC/MS laboratory
of Department of Drug Discovery and Development, Harrison
School of Pharmacy, Auburn University
Results and discussion
Development of the GC/MS method
The primary goal of this study was to provide a direct, fast and
reliable method for the separation and quantiﬁcation of DMH
in presence of its related substances and impurities. In this
regard, several non-polar capillary GC columns were evaluat-
ed in an effort to ﬁnd the appropriate stationary phase provid-
ing the optimum separation. The investigated stationary
phases included the 5% diphenyl/95% dimethyl polysiloxane
(Rtx-5 Amine), 100% dimethyl polysiloxane (Rtx-1) and tri-
ﬂuoropropylmethyl polysiloxane (Rtx-200). The tested capil-
lary GC columns were obtained from Restek Corporation
(Bellefonte, PA, USA). Excellent separation of all the peaks
within short analysis time was only obtained with the triﬂuoro-
propylmethyl polysiloxane (Rtx-200) column. Other columns
failed to separate peaks of the structurally related compounds
benzhydrol and benzophenone, in addition, insufﬁcient resolu-
tion was observed between the peaks of DMH and 8-chloro-
caffeine upon using the Rtx-1 column. Another positive
feature of the Rtx-200 column was the relatively shorter reten-
tion times for all the peaks, e.g., retention time of the parent
drug DMH on the Rtx-200 column was 35% and 25% shorter
than those obtained with the Rtx-5 Amine and Rtx-1 columns
respectively. Several temperature programs were evaluated and
a program showing the best resolution in a reasonable analysis
time was selected. The optimized temperature program started
with an initial hold at 100 C for 1 min, ramped up to 180 C
at a rate of 25 C/min, held at 180 C for 8 min then ramped to250 C at a rate of 25 C/min. Programs with higher initial
temperatures or higher ramp rates led to poor resolution espe-
cially between the two related substances (caffeine and 8-
chlorocaffeine), while lower temperature ramps resulted in
longer retention times and excessive peak tailing. It is notewor-
thy to mention that DMH produces 2 peaks at 7.60 and
14.01 min corresponding to its two components diphenhy-
dramine and 8-chlorotheophylline respectively. Column per-
formance can be expressed by the number of theoretical
plates (N) which equals about 8150 and 9890 for diphenhy-
dramine and 8-chlorotheophylline respectively. Tailing factors
for these 2 peaks are 1.04 and 0.86 respectively. The studied
related substances eluted at retention times 4.24, 5.82, 6.55,
8.51, 11.90 and 12.13 min for diphenylmethane, benzhydrol,
benzophenone, orphenadrine, caffeine and 8-chlorocaffeine,
respectively. Resolution was calculated between each of the
two peaks of DMH and their nearest related substances’
peaks. Resolution was found not less than 2.02, which repre-
sents successful and complete baseline separation. A typical
GC chromatogram for the separation of DMH and its related
substances is shown in Fig. 2. Mass spectrometry is a very use-
ful technique for providing conﬁrmation of chemical structure.
The electron-impact (EI) mass spectrum can be considered a
molecular ﬁngerprint for the identiﬁcation of compounds.
Retention times as well as masses of the molecular ions and
base peak fragments of the studied compounds are listed in
Table 1.
Validation of the proposed method
The proposed method was validated according to the Interna-
tional Conference on Harmonization (ICH) guidelines on
validation of analytical procedures [24].
Linearity and concentration range
As mentioned earlier, DMH produces 2 well separated peaks
(Fig. 2), however, the peak corresponding to diphenhydramine
is much better in shape and provides higher area values and
more reliable measurement than that of 8-chlorotheophylline;
therefore quantiﬁcation of DMH was based on measurement
of diphenhydramine peak areas. The same principle was
applied in previous publications dealing with the HPLC analy-
sis of DMH based on the diphenhydramine component only
[7,8]. The linearity of the proposed GC procedure was
evaluated by analyzing a series of different concentrations of
DMH (n= 8) over the concentration range 50–500 lg/mL.
The following linear regression equation was generated
by least squares treatment of the calibration data:
A= 942752 + 22958C, (r2 = 0.9982), where A and C are
the peak area and concentration of DMH respectively. Other
statistical parameters such as standard deviations of the inter-
cept (Sa) and the slope (Sb) were calculated: 111,731 and 396
respectively. Consequently, deviation around the slope was
evaluated by calculation of the RSD% of the slope (Sb%)
which was found 1.73%. Finally, conﬁdence intervals of the
intercept and the slope were 1216,149 to 669,356 and
21,989–23,926 respectively.
Limits of detection and quantiﬁcation
The limit of detection (LOD) is deﬁned as the concentration
that has a signal-to-noise ratio of 3:1, while for limit of
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Fig. 2 GC/MS chromatogram of a mixture containing diphenylmethane (1), benzhydrol (2), benzophenone (3), DMH (diphenhy-
dramine) (4), orphenadrine (5), caffeine (6), 8-chlorocaffeine (7) and DMH (8-chlorotheophylline) (8).
Table 1 Retention times and important mass fragments of the studied compounds.
Compound Retention time (min) Molecular ion (m/z) Base peak (m/z)
Diphenylmethane 4.24 168 167
Benzhydrol 5.82 184 105
Benzophenone 6.55 182 105
DMH (diphenhydramine) 7.60 255 58
Orphenadrine 8.51 269 58
Caﬀeine 11.90 194 194
8-Chlorocaﬀeine 12.13 228 228
DMH (8-chlorotheophylline) 14.01 214 214
56 T.S. Belal et al.quantiﬁcation (LOQ) the ratio considered is 10:1. The LOD
and LOQ values of DMH were calculated and they were found
to be 9.31 and 31.03 lg/mL respectively which can be consid-
ered sufﬁcient for quality control analysis of DMH in its phar-
maceutical formulation.
Precision and accuracy
The within-day (intra-day) precision and accuracy for the pro-
posed method were studied at three concentration levels for
DMH using three replicate determinations for each concentra-
tion within one day. Similarly, the between-day (inter-day) pre-
cision and accuracy were tested by analyzing the same threeTable 2 Precision and accuracy for the determination of DMH usi
Nominal value (lg/mL) Foun
Within-day 100 100.2
200 197.1
400 389.6
Between-day 100 98.8
200 196.2
400 396.1
a Mean ± standard deviation for three determinations.
b %Relative standard deviation.
c %Relative error.concentrations using three replicate determinations repeated
on three days. Recoveries were calculated using the corre-
sponding regression equation and they were satisfactory. The
percentage relative standard deviation (RSD%) and percent-
age relative error (Er%) did not exceed 3% illustrating the
acceptable precision and accuracy of the developed method
for the estimation of DMH (Table 2).
Speciﬁcity
Speciﬁcity is deﬁned as the ability to access unequivocally the
analyte in the presence of components that may be expected to
be present, such as impurities, degradation products andng the proposed GC/MS method.
d ± SDa (lg/mL) RSD (%)b Er (%)
c
2 ± 2.39 2.39 0.22
2 ± 3.42 1.74 1.44
7 ± 6.95 1.78 2.58
8 ± 2.78 2.81 1.12
5 ± 4.04 2.06 1.87
1 ± 7.47 1.89 0.97
Table 3 Application of the proposed GC/MS method to the
analysis of DMH in Dramamine tablets.
Parameters GC/MS method Reference HPLC method
%Recovery ± SDa 98.85 ± 1.84 98.46 ± 1.17
RSD%b 1.86 1.19
t 0.40
F 2.48
Theoretical values for t and F at P= 0.05 are 2.31 and 6.39,
respectively.
a Mean ± standard deviation for ﬁve determinations.
b %Relative standard deviation.
Selective determination of dimenhydrinate using GC/MS 57matrix components [24]. Method speciﬁcity was already
demonstrated by the successful resolution of DMH from its
related substances and potential impurities (Fig. 2).
Robustness
The robustness of an analytical procedure is a measure of its
capability to remain unaffected by small but deliberate varia-
tions in method parameters and provides an indication of its
reliability during normal usage [24]. Robustness was examined
by evaluating the inﬂuence of small variations in the injector
temperature (300 ± 5 C), starting oven temperature
(100 ± 5 C) and ramp of both steps in the applied tem-
perature program (25 ± 2 C/min). These variations did not
have any signiﬁcant effect on retention times of all the separat-
ed peaks or the measured response (peak area of DMH).
RSD% for retention times of any of the separated peaks and
DMH peak area did not exceed 5% and 3% respectively.
Additionally, these minor experimental changes did not affect
the resolution between any of the separated compounds.
Stability of solutions
Acetonitrile was found to be the appropriate solvent for
preparing both stock and working solutions of the parent
drug and its related substances in this study. Stability of
working solutions in acetonitrile was tested and they were
found to be stable for at least 3 days at room temperature.
Retention times of the studied compounds remained
unchanged and no degradation was observed during this peri-
od. Additionally, the DMH percentage recoveries were not
less than 96%.
Analysis of tablets dosage forms
The developed GC/MS method was applied for the assay of
DMH in its commercial pharmaceutical formulation (Dra-
mamine tablets). DMH was extracted from the tablet pow-
der using acetonitrile then dilution was done with the same
solvent to reach the ﬁnal concentration levels. No interfering
peaks were observed from any of the excipients of the assayed
tablets. A representative chromatogram obtained from the
tablet extract is shown in Fig. 3. The direct determination of
DMH in its tablets without any interference from the inactive4.00 5.00 6.00 7.00 8.00 9
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Fig. 3 GC/MS chromatogram of a solution containingingredients can be considered further evidence for the sim-
plicity and selectivity of the proposed method. Results
obtained were precise, accurate and in good agreement with
the label claim as displayed by the adequate values of percent-
age recoveries, standard deviation and RSD% (Table 3).
The USP reference liquid chromatographic method was
adopted for the estimation of DMH in its tablets [25]. Recov-
ery data obtained from the proposed GC/MS method were sta-
tistically compared with those of the reference USP method
using the Student’s t- and the variance ratio F-tests. In both
tests, the calculated values did not exceed the theoretical ones
at the 95% conﬁdence level which indicated that there were no
signiﬁcant differences between the proposed and the reference
method (Table 3). It can be concluded that the satisfactory
analytical performance of the method fortiﬁes its aptness for
the routine and selective analysis of DMH in quality control
units.
Conclusions
In this study, a simple, rapid and selective GC/MS procedure
for determination of dimenhydrinate (DMH) in presence of six
of its related substances was established. The method is consid-
ered direct using only acetonitrile as a solvent for preparation
of both stock and working solutions. The samples did not
require derivatization or pretreatment and the chromatograms
showed excellent resolution between the parent compound and.00 10.00 11.00 12.00 13.00 14.00
400 lg/mL DMH obtained from Dramamine tablets.
58 T.S. Belal et al.its potential impurities. Very few GC/MS methods can be
found in the scientiﬁc literature for the analysis of DMH mere-
ly for toxicological and forensic purposes. To the best of our
knowledge, there are no GC/MS reports for determination
of the drug in its tablets dosage form. Furthermore, very few
stability indicating or impurity proﬁling methods for DMH
could be found in the literature, and they depended only on
HPLC. This is the ﬁrst GC method developed for the selective
determination of DMH in presence of its related substances
and impurities. The method can be applied in two main ﬁelds:
ﬁrst; separation and identiﬁcation of the expected impurities of
DMH; second; the quality control assay of DMH tablet
dosage form. In both applications, the method showed good
analytical performance and acceptable accuracy and precision.
Based on the results of this study, the GC/MS method can be
used for testing DMH identity, assay, and purity.
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